ArticleCancer gene therapy2020

CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma.

Luqing Tong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.